Find Abrocitinib manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

NDC API

NDC API

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Abrocitinib, 1622902-68-4, Pf-04965842, Cibinqo, Abrocitinib [usan], 73sm5sf3or
Molecular Formula
C14H21N5O2S
Molecular Weight
323.42  g/mol
InChI Key
IUEWXNHSKRWHDY-UHFFFAOYSA-N
FDA UNII
73SM5SF3OR

Abrocitinib
Abrocitinib is under investigation in clinical trial NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis).
Abrocitinib is a Janus Kinase Inhibitor. The mechanism of action of abrocitinib is as a Janus Kinase Inhibitor, and P-Glycoprotein Inhibitor.
1 2D Structure

Abrocitinib

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide
2.1.2 InChI
InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)
2.1.3 InChI Key
IUEWXNHSKRWHDY-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3
2.2 Other Identifiers
2.2.1 UNII
73SM5SF3OR
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-propanesulfonamide, N-(cis-3-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclobutyl)-

2. Abrocitinib

3. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide

4. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide

5. Pf-04965842

2.3.2 Depositor-Supplied Synonyms

1. Abrocitinib

2. 1622902-68-4

3. Pf-04965842

4. Cibinqo

5. Abrocitinib [usan]

6. 73sm5sf3or

7. Chembl4101725

8. N-[3-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide

9. N-{cis-3-[methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide

10. 1-propanesulfonamide, N-(cis-3-(methyl-7h-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclobutyl)-

11. N-(3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide, Cis-

12. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

13. N-[cis-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide

14. Unii-73sm5sf3or

15. D7d

16. N-((1s,3s)-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

17. N-((1s,3s)-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide

18. Abrocitinib [inn]

19. Abrocitinib [jan]

20. Abrocitinib (jan/usan)

21. Abrocitinib [who-dd]

22. Gtpl9991

23. Chembl3655081

24. Schembl15970412

25. Schembl15970413

26. Pf-04965842(abrocitinib)

27. Bdbm159748

28. Dtxsid301126581

29. Pf-04965842 (abrocitinib)

30. Bcp30441

31. Ex-a3037

32. Xpc90268

33. Ac8575

34. Bdbm50243847

35. Mfcd30187577

36. S8765

37. Zb1566

38. Zinc261115849

39. Db14973

40. Sb18849

41. Compound 25 [pmid: 29298069]

42. Ncgc00601823-02

43. Ac-36318

44. As-84437

45. Sy248874

46. Hy-107429

47. Cs-0028460

48. Pf04965842

49. D11400

50. Us9035074, 2

51. A936574

52. Pf-04965842, >=98% (hplc)

53. Pf-04965842pf-04965842

54. Pf-04965842; Pf 04965842; Pf04965842

55. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide

56. N-(cis-3-(methyl(7h-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide

57. Abrocitinib;n-[cis-3-(methyl-7h-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide

2.4 Create Date
2014-10-06
3 Chemical and Physical Properties
Molecular Weight 323.42 g/mol
Molecular Formula C14H21N5O2S
XLogP31.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count6
Exact Mass323.14159610 g/mol
Monoisotopic Mass323.14159610 g/mol
Topological Polar Surface Area99.4 Ų
Heavy Atom Count22
Formal Charge0
Complexity474
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Protein Kinase Inhibitors

Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)


5.2 FDA Pharmacological Classification
5.2.1 Active Moiety
ABROCITINIB
5.2.2 FDA UNII
73SM5SF3OR
5.2.3 Pharmacological Classes
Mechanisms of Action [MoA] - P-Glycoprotein Inhibitors
5.3 ATC Code

D11AH


D - Dermatologicals

D11 - Other dermatological preparations

D11A - Other dermatological preparations

D11AH - Agents for dermatitis, excluding corticosteroids

D11AH08 - Abrocitinib


API SUPPLIERS

read-more
read-more

01

Moehs Iberica

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Moehs Iberica

02

Metrochem API Private Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Metrochem

03

Egis Pharmaceuticals PLC

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEgis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Flag Hungary
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Egis Pharmaceuticals

04

HRV Pharma

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
HRV Global Life Sciences

05

TAPI Technology & API Services

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
TAPI Company Banner

06

Maithri Drugs

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Delivering Trusted, High-Quality APIs to 35+ Countries with Innovation, Compliance, and Excellence.

Flag India
Digital Content Digital Content
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF BR arrow-down AUDIT
Company Banner

07

Changzhou Pharmaceutical Factory

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

ChemOutsourcing
Not Confirmed
arrow

Changzhou Pharmaceutical Factory

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
ChemOutsourcing
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Micro Labs Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

ChemOutsourcing
Not Confirmed
arrow

Micro Labs Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
ChemOutsourcing
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Apicore

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

ChemOutsourcing
Not Confirmed
arrow

Apicore

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
ChemOutsourcing
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

Pfizer Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

ChemOutsourcing
Not Confirmed
arrow

Pfizer Inc

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
ChemOutsourcing
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMoehs Group, a reference company in the production of pharmaceutical active ingredients.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38879

Submission : 2023-09-15

Status : Active

Type : II

Moehs Iberica

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Delivering Trusted, High-Quality APIs to 35+ Countries with Innovation, Compliance, and Excellence.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 41402

Submission : 2025-02-28

Status : Active

Type : II

Company Banner

03

ChemOutsourcing
Not Confirmed

03

ChemOutsourcing
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-05-06

Pay. Date : 2025-03-27

DMF Number : 39291

Submission : 2023-12-27

Status : Active

Type : II

blank

04

Micro Labs Ltd

India

USDMF

arrow
ChemOutsourcing
Not Confirmed

04

ChemOutsourcing
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2025-07-24

Pay. Date : 2025-07-11

DMF Number : 41868

Submission : 2025-06-20

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1686508200,"product":"ABROCITINIB","address":"NO 31, RACE COURSE ROAD BANGALORE Contact No: 919945641620","city":"BENGALURU","supplier":"MICRO LABS LTD","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"APOTEX INC SIGNET","customerCountry":"CANADA","quantity":"0.06","actualQuantity":"0.06","unit":"KGS","unitRateFc":"65000","totalValueFC":"3783.6","currency":"USD","unitRateINR":5183328.1500000004,"date":"12-Jun-2023","totalValueINR":"310999.689","totalValueInUsd":"3783.6","indian_port":"BANGALORE AIR","hs_no":"29333100","bill_no":"0","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"NO 31, RACE COURSE ROAD BANGALORE Contact No: 919945641620, BENGALURU","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1681929000,"product":"ABROCITINIB ( LABORATORY REGENT FOR RESEARCH PURPOSE)","address":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III","city":"NEW DELHI,DELHI","supplier":"HANGZHOU PROSERRE CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"NA","customer":"MANKIND PHARMA LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"12000","totalValueFC":"1213.1","currency":"USD","unitRateINR":"994200","date":"20-Apr-2023","totalValueINR":"99420","totalValueInUsd":"1213.1","indian_port":"DELHI AIR","hs_no":"29339990","bill_no":"5598469","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"208, OKHLA INDUSTRIAL ESTATE,,PHAS E III"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714415400,"product":"ABROCITINIB","address":"20TH KM, HOSUR ROAD,","city":"BANGALORE","supplier":"NANTONG CHANYOO PHARMATECH CO LTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"BIOCON PHARMA LTD","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"8000","totalValueFC":"24256.6","currency":"USD","unitRateINR":"675200","date":"30-Apr-2024","totalValueINR":"2025600","totalValueInUsd":"24256.6","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"1005277","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"NO.2 TONGHAI SI ROAD, YANGKOU CHEMICALINDL PARK,RUDONG COASTAL ECONOMIC DEVELOPMENT ZONE, NANTONG JIANGSU","customerAddress":"20TH KM, HOSUR ROAD,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722882600,"product":"ABROCITINIB","address":"20TH KM, HOSUR ROAD,","city":"BANGALORE","supplier":"NANTONG CHANYOO PHARMATECH COLTD","supplierCountry":"CHINA","foreign_port":"SHANGHAI","customer":"BIOCON PHARMA LTD","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5","unit":"KGS","unitRateFc":"8000","totalValueFC":"40344","currency":"USD","unitRateINR":"676800","date":"06-Aug-2024","totalValueINR":"3384000","totalValueInUsd":"40344","indian_port":"Biocon-SEZ","hs_no":"29420090","bill_no":"4906514","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"SHANGHAI","supplierAddress":"No.2 Tonghai Si Road,Yangkou Chemic al Industrial Park, Rudong Coastal SDNF China","customerAddress":"20TH KM, HOSUR ROAD,"}]
20-Apr-2023
06-Aug-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Company : Pfizer US Pharm

Abrocitinib

Drug Cost (USD) : 9,784,290

Year : 2023

Prescribers : 347

Prescriptions : 1528

blank

02

arrow
ChemOutsourcing
Not Confirmed
arrow
ChemOutsourcing
Not Confirmed

Company : Pfizer US Pharm

Abrocitinib

Drug Cost (USD) : 1,849,145

Year : 2022

Prescribers : 119

Prescriptions : 327

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Regulatory FDF Prices

read-more
read-more

01

Brand Name : Cibinqo

U.S.A
arrow
ChemOutsourcing
Not Confirmed

Brand Name : Cibinqo

U.S.A
arrow
ChemOutsourcing
Not Confirmed

Abrocitinib

Dosage Form : Film-Coated Tablets

Dosage Strength : 100mg

Price Per Pack (Euro) : 937.81

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

02

Brand Name : Cibinqo

U.S.A
arrow
ChemOutsourcing
Not Confirmed

Brand Name : Cibinqo

U.S.A
arrow
ChemOutsourcing
Not Confirmed

Abrocitinib

Dosage Form : Film-Coated Tablets

Dosage Strength : 50mg

Price Per Pack (Euro) : 937.81

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

read-more
read-more

01

Brand Name : Cibinqo

Abrocitinib

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Cibinqo

U.S.A
arrow
ChemOutsourcing
Not Confirmed

Abrocitinib

Main Therapeutic Indication : Dermatology

Currency : USD

2023 Revenue in Millions : 128

2022 Revenue in Millions : 27

Growth (%) : 374

blank

02

Brand Name : Cibinqo

Abrocitinib

arrow
ChemOutsourcing
Not Confirmed

Brand Name : Cibinqo

U.S.A
arrow
ChemOutsourcing
Not Confirmed

Abrocitinib

Main Therapeutic Indication : Dermatology

Currency : USD

2024 Revenue in Millions : 215

2023 Revenue in Millions : 128

Growth (%) : 68

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9549929

Drug Substance Claim :

Drug Product Claim :

Application Number : 213871

Patent Use Code : U-3195

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

02

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9549929

Drug Substance Claim :

Drug Product Claim :

Application Number : 213871

Patent Use Code : U-3195

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

03

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9549929

Drug Substance Claim :

Drug Product Claim :

Application Number : 213871

Patent Use Code : U-3195

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

04

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9035074

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213871

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

05

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9545405

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213871

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

06

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9035074

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213871

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

07

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9545405

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213871

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

08

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9545405

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213871

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank

09

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

US Patent Number : 9035074

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 213871

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-02-19

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-01-14

Application Number : 213871

Product Number : 1

Exclusivity Details :

blank

02

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-02-09

Application Number : 213871

Product Number : 1

Exclusivity Details :

blank

03

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-01-14

Application Number : 213871

Product Number : 2

Exclusivity Details :

blank

04

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-02-09

Application Number : 213871

Product Number : 2

Exclusivity Details :

blank

05

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

Exclusivity Code : NCE

Exclusivity Expiration Date : 2027-01-14

Application Number : 213871

Product Number : 3

Exclusivity Details :

blank

06

arrow
ChemOutsourcing
Not Confirmed

PFIZER

U.S.A
arrow
ChemOutsourcing
Not Confirmed

ABROCITINIB

Exclusivity Code : NPP

Exclusivity Expiration Date : 2026-02-09

Application Number : 213871

Product Number : 3

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 1622902-68-4 / Abrocitinib API manufacturers, exporters & distributors?

Abrocitinib manufacturers, exporters & distributors 1

100

PharmaCompass offers a list of Abrocitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Abrocitinib manufacturer or Abrocitinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Abrocitinib manufacturer or Abrocitinib supplier.

PharmaCompass also assists you with knowing the Abrocitinib API Price utilized in the formulation of products. Abrocitinib API Price is not always fixed or binding as the Abrocitinib Price is obtained through a variety of data sources. The Abrocitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Abrocitinib

Synonyms

1622902-68-4, Pf-04965842, Cibinqo, Abrocitinib [usan], 73sm5sf3or, Chembl4101725

Cas Number

1622902-68-4

Unique Ingredient Identifier (UNII)

73SM5SF3OR

About Abrocitinib

Abrocitinib is under investigation in clinical trial NCT03796676 (JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis).

Abrocitinib Manufacturers

A Abrocitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Abrocitinib, including repackagers and relabelers. The FDA regulates Abrocitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Abrocitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Abrocitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Abrocitinib Suppliers

A Abrocitinib supplier is an individual or a company that provides Abrocitinib active pharmaceutical ingredient (API) or Abrocitinib finished formulations upon request. The Abrocitinib suppliers may include Abrocitinib API manufacturers, exporters, distributors and traders.

click here to find a list of Abrocitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Abrocitinib USDMF

A Abrocitinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Abrocitinib active pharmaceutical ingredient (API) in detail. Different forms of Abrocitinib DMFs exist exist since differing nations have different regulations, such as Abrocitinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Abrocitinib DMF submitted to regulatory agencies in the US is known as a USDMF. Abrocitinib USDMF includes data on Abrocitinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Abrocitinib USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Abrocitinib suppliers with USDMF on PharmaCompass.

Abrocitinib KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Abrocitinib Drug Master File in Korea (Abrocitinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Abrocitinib. The MFDS reviews the Abrocitinib KDMF as part of the drug registration process and uses the information provided in the Abrocitinib KDMF to evaluate the safety and efficacy of the drug.

After submitting a Abrocitinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Abrocitinib API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Abrocitinib suppliers with KDMF on PharmaCompass.

Abrocitinib GMP

Abrocitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Abrocitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Abrocitinib GMP manufacturer or Abrocitinib GMP API supplier for your needs.

Abrocitinib CoA

A Abrocitinib CoA (Certificate of Analysis) is a formal document that attests to Abrocitinib's compliance with Abrocitinib specifications and serves as a tool for batch-level quality control.

Abrocitinib CoA mostly includes findings from lab analyses of a specific batch. For each Abrocitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Abrocitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Abrocitinib EP), Abrocitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Abrocitinib USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty